Oncogenic nature of a novel mutant AATF and its interactome existing within human cancer cells

被引:11
|
作者
Sharma, Shaveta [1 ]
Kaul, Deepak [1 ]
Arora, Mansi [1 ]
Malik, Deepti [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Mol Biol Unit, Dept Expt Med & Biotechnol, Chandigarh 160012, India
关键词
Cancer cells; DNMT3B; Mutant-AATF; Oncogenomics; AUTOPHAGY; APOPTOSIS; P53; SURVIVAL; CHE-1;
D O I
10.1002/cbin.10379
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Since apoptosis presents a natural defense in cancer development, the anti-apoptotic factor AATF/Che-1 has emerged as a crucial Epigenomic-Switch'. We have tried to understand the double-edged nature of AATF, showing for the first time the conspicuous existence of an aberrant AATF/Che-1 transcriptome encoding for 23kDa mutant AATF protein, which evolves its unique interactome within human cancer cells derived from different tissue origins. This mutant AATF along with its interactome consisting of SP1, DNMT3B and Par-4 ensures cancer cell DNA methylation required for down-regulation of tumor suppressor genes. Hence, the proposed mutant AATF interactome-based pathway can have the inherent ability to ensure human cells become and remain cancerous.
引用
收藏
页码:326 / 333
页数:8
相关论文
共 50 条
  • [31] Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ
    M Escoll
    R Gargini
    A Cuadrado
    I M Anton
    F Wandosell
    Oncogene, 2017, 36 : 3515 - 3527
  • [32] Interactome between embryo trophectodermcells and endometrial epithelial and stromal cells: novel insights into implantation process in human
    Koel, M.
    Krjutskov, K.
    Reddy, A.
    Saare, M.
    Katayama, S.
    Kumar, L.
    Danielsson, K. Gemzell
    Lanner, F.
    Einarsdottir, E.
    Blesa, D.
    Simon, C.
    Kere, J.
    Salumets, A.
    Altmae, S.
    HUMAN REPRODUCTION, 2017, 32 : 347 - 347
  • [33] An integrated genomics approach to identify novel drivers of oncogenic pathway activity in human cancer
    Gatza, Michael L.
    Kim, So Young
    Reeves, Jason
    Lucas, Joseph E.
    Nevins, Joseph R.
    CANCER RESEARCH, 2012, 72
  • [34] A novel role for PACS-1 in suppression of oncogenic replication stress in cancer cells
    Mani, Chinnadurai
    Tripathi, Kaushlendra
    Clark, David W.
    Thomas, Gary
    Palle, Komaraiah
    CANCER RESEARCH, 2020, 80 (16)
  • [35] An oncogenic activity of PDGF-C and its splice variant in human breast cancer
    Bottrell, Alyssa
    Meng, Yong Hong
    Najy, Abdo J.
    Hurst, Newton
    Kim, Seongho
    Kim, Chong Jai
    Kim, Eun-Sook
    Moon, Aree
    Kim, Eun Joo
    Park, So Yeon
    Kim, Hyeong-Reh Choi
    GROWTH FACTORS, 2019, 37 (3-4) : 131 - 145
  • [36] ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells
    Stohr, Bradley A.
    Blackburn, Elizabeth H.
    CANCER RESEARCH, 2008, 68 (13) : 5309 - 5317
  • [37] Apremilast Induces Apoptosis of Human Colorectal Cancer Cells with Mutant KRAS
    Nishi, Kensuke
    Luo, Hao
    Ishikura, Shuhei
    Doi, Keiko
    Iwaihara, Yuri
    Wills, Lauren
    Baillie, George S.
    Sakata, Toshifumi
    Shirasawa, Senji
    Tsunoda, Toshiyuki
    ANTICANCER RESEARCH, 2017, 37 (07) : 3833 - 3839
  • [38] Expression of Mutant RPA in Human Cancer Cells Causes Telomere Shortening
    Kobayashi, Yuka
    Sato, Koichiro
    Kibe, Tatsuya
    Seimiya, Hiroyuki
    Nakamura, Asako
    Yukawa, Masashi
    Tsuchiya, Eiko
    Ueno, Masaru
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2010, 74 (02) : 382 - 385
  • [39] Isogenic mutant human cells A new tool for personalized cancer medicine
    Di Nicolantonio, Federica
    Arena, Sabrina
    Gallicchio, Margherita
    Bardelli, Alberto
    CELL CYCLE, 2010, 9 (01) : 20 - 21
  • [40] Proteomic analysis of DZIP3 interactome and its role in proliferation and metastasis in gastric cancer cells
    Qiu, Rongfang
    Zhao, Siyu
    Lu, Chenying
    Xu, Ziwei
    Shu, Enfen
    Weng, Qiaoyou
    Chen, Weiqian
    Fang, Shiji
    Chen, Weiyue
    Zheng, Liyun
    Zhao, Zhongwei
    Yang, Yang
    Ji, Jiansong
    EXPERIMENTAL CELL RESEARCH, 2023, 425 (01)